Table 3.

Current guidelines for using cardiac magnetic resonance in evaluation of heart failure (3, 4).

Recommendations	Guidelines	COR	LOE
In patients for whom echocardiography is inadequate	2022 AHA	I	C
	2021 ESC	I	C
For the characterization of myocardial tissue in suspected infiltrative diseases	2021 ESC	I	C
In patients with heart failure or cardiomyopathy	2022 AHA	IIa	B
In patients with heart failure, an evaluation for ischemic heart diseases	2022 AHA	IIa	B
In patients with dilated cardiomyopathy to distinguish between ischemic and nonischemic myocardial damages	2021 ESC	IIa	C
In patients with heart failure and coronary artery disease to assess myocardial ischemia and viability for coronary revascularization	2022 AHA	IIb	B
	2021 ESC	IIb	B

AHA, American heart association; ESC, European society of cardiology.